Wound healing, viral suppression linked to less HIV shedding from circumcision wounds

April 28, 2015

The likelihood of viral shedding from male circumcision wounds intially increases, then decreases as the wounds heal, and is lower in patients with lower plasma viral load, according to a study published this week in PLOS Medicine. The study, conducted by Aaron Tobian, of Johns Hopkins University, Baltimore, MD and the Rakai Health Sciences Program, Entebbe, Uganda, and colleagues, monitored 223 HIV-infected men for wound healing and viral shedding from their surgical wounds for 12 weeks following voluntary medical male circumcision.

The researchers found that, compared to specimens obtained from washings of the surgical site before circumcision, HIV viral shedding in the area of the surgical site was more common in weeks 1, 2, and 3 after surgery, (by 87%, 216% and 98% of men, respectively). However, by six weeks after surgery, all wounds had healed and viral shedding decreased. Compared to baseline, shedding was detected in 73% and 81% fewer men at weeks 6 and 12 after surgery, respectively. Overall, they found that viral shedding from the surgical site was 88% less common in visits from men with healed surgical wounds compared to men whose wounds were still healing.

In addition to wound healing, lower amounts of virus in the blood was also associated with less viral shedding. At enrollment, 40 men reported being on antiretroviral treatment (ART), 29 of whom had undetectable plasma viral load. HIV shedding was more 10 times less likely in men with low or undetectable plasma viral load (<400 copies>50,000 copies/ml), and when virus was detected in washings from the wounds of men with ART-suppressed viral loads, it was at lower levels than in men not on ART.

The authors say:

"The findings from this study reinforce the need for male circumcision programs to provide voluntary HIV counseling and testing prior to MC, promote sexual abstinence during wound healing and condom use thereafter, offer free condoms, and encourage counseling for HIV-infected men and their sexual partners on the risk of HIV transmission if sexual intercourse is resumed prior to complete wound healing."
-end-
Research Article

Funding: This study was supported by the Bill & Melinda Gates Foundation (22006.03, sample collection), the Doris Duke Charitable Foundation (#2011036, laboratory work), the Division of Intramural Research, National Institute of Allergy and Infectious Diseases and the Fogarty International Center, 1D43TWOO9578-01. AART was supported by the NIH 1K23AI093152-01A1 and the Doris Duke Charitable Foundation Clinician Scientist Development Award. MKG was supported by NIH T32AI102 and the Doris Duke Charitable Foundation Clinician Scientist Development Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests: JL is a member of the Editorial Board of PLOS Medicine. All other authors have declared that no competing interests exist.

Citation: Tobian AAR, Kigozi G, Manucci J, Grabowski MK, Serwadda D, et al. (2015) HIV Shedding from Male Circumcision Wounds in HIV-Infected Men: A Prospective Cohort Study. PLoS Med 12(4): e1001820. doi:10.1371/journal.pmed.1001820

Author Affiliations:

Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America; Rakai Health Sciences Program, Entebbe, Uganda; Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America; Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America; Institute of Public Health, Makerere University, Kampala, Uganda; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America;

Contact:

Aaron A. R. Tobian Johns Hopkins University atobian1@jhmi.edu

PLOS

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.